Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.
Wasatch Micro Cap Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 12.2% for the quarter, outperforming its benchmark, the Russell Microcap Index which returned 3.69% in the same quarter. You should check out Wasatch’s top 5 stock picks for investors to […]
How far off is BioLife Solutions, Inc. ( NASDAQ:BLFS ) from its intrinsic value? Using the most recent financial data...
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and successful investors’ positions as of the end of the third quarter. You can find articles about an individual hedge fund’s trades on numerous financial […]
Casdin Capital lifted its stake in the hypothermic-storage firm BioLife. Nimbus Holdings cut it investment in Nikola, a maker of alternative-fuel-powered vehicles.
Technology targets critical shortage of viral vectors for the rapidly expanding field of cell and gene therapeuticsWORCESTER, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- iVexSol, a rapidly growing lentiviral vector (LVV) manufacturing company, today announced the closure of a $13.0M Series A funding round. A total of $15.2M has been raised to date from current investors Casdin Capital, LLC , and BioLife Solutions (NASDAQ:BLFS) and a third undisclosed lead investor. Funds will be used to establish a...
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced two new co-investments with innovation accelerator partner Casdin Capital. The first is a re-investment in iVexSol, a vector manufacturing company founded on a proprietary, next-generation, stable lentiviral vector production process. BioLife Solutions invested $1 million and Casdin ...
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced it was ranked number 403 on Deloitte's Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. BioLife Solutions' revenue grew 233% from 2016 through 2019.